These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26935218)

  • 1. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
    Mussazhanova Z; Akazawa Y; Matsuda K; Shichijo K; Miura S; Otsubo R; Oikawa M; Yoshiura K; Mitsutake N; Rogounovitch T; Saenko V; Kozykenova Z; Zhetpisbaev B; Shabdarbaeva D; Sayakenov N; Amantayev B; Kondo H; Ito M; Nakashima M
    Endocr J; 2016 May; 63(5):457-67. PubMed ID: 26935218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Diagnostic Method for Thyroid Follicular Tumors Based on Immunofluorescence Analysis of p53-Binding Protein 1 Expression: Detection of Genomic Instability.
    Otsubo R; Matsuda K; Mussazhanova Z; Sato A; Matsumoto M; Yano H; Oikawa M; Kondo H; Ito M; Miyauchi A; Hirokawa M; Nagayasu T; Nakashima M
    Thyroid; 2019 May; 29(5):657-665. PubMed ID: 30929573
    [No Abstract]   [Full Text] [Related]  

  • 3. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis.
    Nakashima M; Suzuki K; Meirmanov S; Naruke Y; Matsuu-Matsuyama M; Shichijo K; Saenko V; Kondo H; Hayashi T; Ito M; Yamashita S; Sekine I
    Int J Cancer; 2008 Mar; 122(5):1082-8. PubMed ID: 17985346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
    Metovic J; Vignale C; Annaratone L; Osella-Abate S; Maletta F; Rapa I; Cabutti F; Patriarca S; Gallo M; Nikiforov YE; Volante M; Papotti M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32936917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
    Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
    Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncocytic Follicular Cell-Derived Thyroid Tumors With Papillary Growth Pattern: A Clinicopathologic Study of 32 Cases.
    Suster D; Ronen N; Giorgadze T; Baisre-de Leon A; Montalvan I; Suster S
    Arch Pathol Lab Med; 2024 Sep; 148(9):997-1006. PubMed ID: 38100177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.
    Weber F; Aldred MA; Morrison CD; Plass C; Frilling A; Broelsch CE; Waite KA; Eng C
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1149-55. PubMed ID: 15546898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
    Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
    J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
    Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
    Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
    Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
    Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
    Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
    Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
    Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
    Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
    Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA copy number variations characterize benign and malignant thyroid tumors.
    Liu Y; Cope L; Sun W; Wang Y; Prasad N; Sangenario L; Talbot K; Somervell H; Westra W; Bishop J; Califano J; Zeiger M; Umbricht C
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E558-66. PubMed ID: 23345095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors.
    Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y
    Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
    Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
    PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.